The main focus of NIH’s conflict of interest (COI) policy is to identify and manage financial conflicts of interest so that NIH‑funded research is designed, conducted, and reported without bias.

Core purpose in simple terms

  • NIH’s COI rules are centered on “financial conflicts of interest,” meaning situations where an investigator’s personal financial interests (e.g., equity, consulting fees, patents) could affect their research decisions.
  • The goal is to promote objectivity in research by ensuring that any significant financial interests that might bias a project are disclosed, reviewed, and appropriately managed or eliminated.

What the policy aims to protect

  • Research integrity : The policy is designed to provide a “reasonable expectation” that NIH‑funded research will be free from bias stemming from investigators’ conflicting financial interests.
  • Public trust : NIH emphasizes that, as a public agency, it must maintain public confidence that its funded studies are objective, scientifically sound, and not unduly influenced by outside financial relationships.

How this focus works in practice

  • Investigators must disclose significant financial interests related to their institutional responsibilities so institutions can determine if a financial conflict of interest exists.
  • Institutions then decide how to manage the conflict (e.g., management plans, oversight, divestiture, or limiting certain roles) and must report identified financial conflicts of interest and their management to NIH.

TL;DR: The main focus of NIH’s conflict of interest policy is managing financial conflicts of interest to keep NIH‑funded research objective and worthy of public trust.

Information gathered from public forums or data available on the internet and portrayed here.